RGEN News and Press, Repligen Corporation From 05/01/24

2024-05-01 07:32:52 ET More on Repligen Repligen misses top-line and bottom-line estimates; initiates FY24 outlook Seeking Alpha’s Quant Rating on Repligen Historical earnings data for Repligen Read the full article on Seeking Alpha For further...

Reports first quarter revenue of $151 million Increased new modalities revenue by 16% year-over-year Increased Filtration (non-COVID) revenue by 12% year-over-year Achieved a nine-month book-to-bill ratio of 1.03 WALTHAM, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Rep...

2024-04-30 11:52:33 ET More on Repligen Repligen Corporation (RGEN) Q4 2023 Earnings Call Transcript Repligen misses top-line and bottom-line estimates; initiates FY24 outlook Repligen Q4 2023 Earnings Preview Seeking Alpha’s Quant Rating on Repligen ...

2024-04-25 17:01:08 ET Summary Danaher Corporation stock has surged by 16% since our "Strong Buy" rating in June 2023, outperforming the S&P 500. The bioprocessing industry is facing near-term challenges, but long-term growth prospects remain strong. Danaher's Q1 FY24 resu...

2024-04-24 09:10:00 ET Summary Artisan Partners is an independent investment management firm focused on providing high value-added, active investment strategies to sophisticated clients globally. Our portfolio outperformed the Russell Midcap® Growth Index in Q1 due to balance...

Repligen Corporation (NASDAQ: RGEN) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 9.58% on the day to $172.57. Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biologic...

2024-04-23 09:30:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. In the quarter ended March 31, 2024, Baron Health Care Fund advanced 8.92% compared wi...

2024-04-23 06:58:24 ET More on Danaher Danaher: All In On Life Sciences, And Market Update Danaher Corporation (DHR) TD Cowen 44th Annual Health Care Conference (Transcript) Danaher: Better Positioned For The Future Danaher Non-GAAP EPS of $1.92 beats by $0.2...

WALTHAM, Mass., April 17, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first quarter 2024 financial results on Wednesday, May 1, 2024. The Company will issue a press release before the market opens and will host a conference call at ...

2024-04-10 12:49:59 ET Summary Thermo Fisher Scientific, Danaher Corporation, and Agilent Technologies are leading companies in the life science tools industry. Despite a long history of success with those firms, I believe long-term investors should diversify into growth opportuni...